Wen Hsiang Lai
Chairman bij CENTURY IRON AND STEEL INDUSTRIAL CO.,LTD.
Vermogen: 85 M $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Wen Hsiang Lai
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Building Products | 17 | |
| Public Company | Alternative Power Generation | 10 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Wen Hsiang Lai via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| CHINA STEEL CORPORATION | Steel | Director/Board Member | |
| TAIWAN GLASS IND. CORP. | Industrial Specialties | Director/Board Member | |
| FORMOSA TAFFETA CO., LTD. | Textiles | Chief Executive Officer | |
| KENDA RUBBER INDUSTRIAL CO. LTD. | Automotive Aftermarket | Director/Board Member | |
| HSIN KUANG STEEL COMPANY LIMITED | Steel | Chief Executive Officer | |
| FARCENT ENTERPRISE CO.,LTD | Household/Personal Care | Director/Board Member | |
| NORTH-STAR INTERNATIONAL CO., LTD. | Specialty Stores | Director/Board Member | |
| University of Tamkang | College/University | Undergraduate Degree | |
| National Taiwan University | College/University | Graduate Degree | |
| National Chung Hsing University | College/University | Undergraduate Degree | |
| SWANCOR HOLDING CO., LTD. | Chemicals: Specialty | Director/Board Member | |
| SIMULA TECHNOLOGY INC. | Electronic Components | Director/Board Member | |
| Yi Chou Group | Chairman | ||
UWELL Biopharma, Inc.
 UWELL Biopharma, Inc. Pharmaceuticals: MajorHealth Technology UWELL Biopharma, Inc. is a biotech company founded in 2003 and based in New Taipei, Taiwan. The Taiwanese company specializes in developing new cancer drugs using chimeric antigen receptor T-cell (CAR-T) technology. CAR-T therapy involves engineering a patient's T-cells to recognize and attack cancer cells. UWELL is currently conducting an open, single-center phase I clinical trial to evaluate the safety and efficacy of its anti-CD19 CAR-T cell injection in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma. The study has been approved by the Institutional Review Board of Tri-Service General Hospital and the Ministry of Health and Welfare. UWELL has achieved success in treating adult blood cancer patients with CAR-T therapy, as evidenced by the clearance of cancer cells in the first case treated at Tri-Service General Hospital. | Pharmaceuticals: Major | Director/Board Member | |
Yi-Chiu International Development Co. Ltd.
 Yi-Chiu International Development Co. Ltd. Financial ConglomeratesFinance Yi-Chiu International Development Co. Ltd. is a Taiwanese company that provides investment and management consulting services. The private company is based in New Taipei, Taiwan. The company was founded in 2012. | Financial Conglomerates | Director/Board Member | |
Century Huaxin Wind Energy Co. Ltd.
 Century Huaxin Wind Energy Co. Ltd. SteelNon-Energy Minerals Century Huaxin Wind Energy Co. Ltd. is a Taiwanese company that engages in iron and steel processing. The private company is based in Taoyuan City, Taiwan. The company was founded in 2020. The CEO is Kuo Chih Huang. | Steel | Director/Board Member | |
| YI CHUN GREEN TECHNOLOGY CO., LTD. | Environmental Services | Chairman |
Statistieken
Internationaal
| Taiwan | 18 |
Sectoraal
| Non-Energy Minerals | 4 |
| Process Industries | 4 |
| Consumer Services | 4 |
| Consumer Durables | 2 |
| Consumer Non-Durables | 2 |
Operationeel
| Director/Board Member | 33 |
| Independent Dir/Board Member | 14 |
| Chief Executive Officer | 5 |
| Chairman | 4 |
| Public Communications Contact | 4 |
Sterkste connecties
| Insiders | |
|---|---|
| Chia Hung Chin | 8 |
| Sheng Chung Lin | 6 |
| Ming Te Su | 4 |
| Chin Chi Chen | 2 |
| Tien Cheng Yang | 2 |
| Kuang Ming Li | 2 |
| Ming Te Li | 2 |
| Chun Fu Chang | 1 |
| En Guang Mao | 1 |
| Sheng Yuan Qu | 1 |
| Hsuan Pin Lai | 1 |
| Huei Hua Lai | 1 |
| Kuo Chin Chen | 1 |
| Yu Ling Zhang | 1 |
| Ming Zheng Lin | 1 |
- Beurs
- Insiders
- Wen Hsiang Lai
- Bedrijfsconnecties
